High Frequency of Cell-in-Cell Formation in Heterogeneous Human Breast Cancer Tissue in a Patient With Poor Prognosis: A Case Report and Literature Review
Overview
Affiliations
Cell cannibalism is a unique pathological phenomenon that has been observed at low frequency in a variety of human tumor samples (<0.5%), including breast cancer. Cannibalistic cells typically form cell-in-cell (CIC) structures characterized by enclosure of one cell or more by another, mediating a novel type of cell death "entosis," which was proposed as the type IV cell death. A large number of CIC structures are generally associated with malignant transformation and progression, and they are believed to be primed by and form among heterogeneous cells. However, there is currently no evidence from human tumor samples. In this case report, covering a 37-year-old female breast cancer patient, we observed considerable heterogeneity and proliferative activity (>70% Ki-67 positivity) in her breast cancer cells, accompanied by high frequency of CIC formation (~6%) and poor prognosis. We consider this a typical example of cell cannibalism, supporting a role of heterogeneity in cell-in-cell formation and malignant progression. It may serve as a pretest basis for further investigations of cell-in-cell biology and breast cancer treatment.
The battle within: cell death by phagocytosis in cancer.
Zhou L, Fan S, Zhang W, Gong Z, Wang D, Tang D Clin Transl Oncol. 2024; .
PMID: 39167272 DOI: 10.1007/s12094-024-03650-x.
Mechanisms and significance of entosis for tumour growth and progression.
Gaptulbarova K, Tsydenova I, Dolgasheva D, Kravtsova E, Ibragimova M, Vtorushin S Cell Death Discov. 2024; 10(1):109.
PMID: 38429285 PMC: 10907354. DOI: 10.1038/s41420-024-01877-9.
Loss of RND3/RHOE controls entosis through LAMP1 expression in hepatocellular carcinoma.
Basbous S, Dif L, Dantzer C, Di-Tommaso S, Dupuy J, Bioulac-Sage P Cell Death Dis. 2024; 15(1):46.
PMID: 38218945 PMC: 10787830. DOI: 10.1038/s41419-024-06420-3.
Cell-in-cell: a potential biomarker of prognosis and a novel mechanism of drug resistance in cancer.
Liu X, Yang J Front Oncol. 2023; 13:1242725.
PMID: 37637068 PMC: 10449025. DOI: 10.3389/fonc.2023.1242725.
Fate of Entosis: From the Beginning to the End in Untreated Advanced Breast Cancer.
Dziuba I, Gawel A, Tyrna P, Rybczynska J, Bialy L, Mlynarczuk-Bialy I Int J Mol Sci. 2023; 24(15).
PMID: 37569518 PMC: 10418304. DOI: 10.3390/ijms241512142.